Holen Sie sich die Stockscreener-App
1.02
1.98%
0.01
Schlusskurs vom Vortag:
$1.01
Offen:
$1.02
24-Stunden-Volumen:
8,405
Relative Volume:
0.12
Marktkapitalisierung:
$14.06M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.67M
KGV:
-1.0902
EPS:
-0.9356
Netto-Cashflow:
$-9.36M
1W Leistung:
+1.98%
1M Leistung:
+6.75%
6M Leistung:
-34.81%
1J Leistung:
-38.32%
1-Tages-Spanne:
$1.01
$1.0474
1-Wochen-Bereich:
$0.9931
$1.0736
52-Wochen-Spanne:
$0.8588
$2.67
Cocrystal Pharma Inc Stock (COCP) Company Profile
Firmenname
Cocrystal Pharma Inc
Sektor
Branche
Telefon
(786) 459-1831
Adresse
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.02 | 13.92M | 0 | -9.67M | -9.36M | -0.9356 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.28 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.73 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
695.77 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.53 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.50 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-07-08 | Eingeleitet | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Aktie (COCP) Neueste Nachrichten
Why is Cocrystal Pharma Inc stock going up2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
Can Cocrystal Pharma Inc keep up with sector leadersWall Street Watch & Real-Time Buy Signal Notifications - baoquankhu1.vn
Cocrystal Pharma Doses First Subjects in Phase 1b Trial of CDI-988 Oral Antiviral for Norovirus Prevention and Treatment - Minichart
First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment - Bitget
Cocrystal Pharma announces first subjects dosed in Phase 1b study of CDI-988 - TipRanks
Cocrystal Pharma (COCP) Begins Phase 1b Study for Norovirus Trea - GuruFocus
Cocrystal Initiates Phase 1b Norovirus Antiviral Challenge Study - TipRanks
Cocrystal begins dosing patients in norovirus challenge study - Investing.com
First norovirus antiviral trial takes on $60B global cost - Stock Titan
Is Cocrystal Pharma Inc. stock a buy in volatile markets2026 Key Highlights & Weekly Chart Analysis and Trade Guides - Naître et grandir
OMEX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
MGIH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
COCP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Influenza Clinical Trial Pipeline Gains Momentum: 120+ - openPR.com
Aug Catalysts: Should value investors consider CCNEPMarket Trend Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Trust linked to Phillip Frost adds 20K Cocrystal (COCP) shares - Stock Titan
COCP: CDI-988 Data to be Presented at ICAR 2026 - Zacks Small Cap Research
Gains Recap: Why is Cocrystal Pharma Inc stock going upTrade Entry Report & Fast Entry High Yield Tips - baoquankhu1.vn
Winners Losers: Why is Cocrystal Pharma Inc stock going upJuly 2025 Trends & Growth Focused Stock Pick Reports - baoquankhu1.vn
Can Cocrystal Pharma Inc. stock sustain institutional interestWeekly Loss Report & Safe Entry Point Identification - mfd.ru
Why ALRM stock attracts high net worth investorsDividend Hike & Daily Momentum Trading Reports - mfd.ru
Is Cocrystal Pharma Inc. stock risky to hold nowJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - mfd.ru
Investment Report: Can Cocrystal Pharma Inc ride the EV waveJuly 2025 PreEarnings & High Return Stock Watch Alerts - baoquankhu1.vn
Cocrystal Highlights CDI-988 Norovirus Data at ICAR 2026 - TipRanks
Norovirus drug CDI-988 to be presented at ICAR2026 by Cocrystal (NASDAQ: COCP) - Stock Titan
Alta Equipment Group Announces Date of Fourth Quarter and Full Year 2025 Financial Results Release, Conference Call and Webcast - Bitget
CareCloud to Announce Fourth Quarter and Full Year 2025 Results on March 12, 2026 - Bitget
Cocrystal Pharma’s First Oral Norovirus Protease Inhibitor - GlobeNewswire
Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026 - Bitget
Will High Tide Inc. stock outperform growth indexesWeekly Investment Recap & Consistent Growth Stock Picks - mfd.ru
Will HNGE stock profit from automation waveEarnings Recap Report & Capital Protection Trade Alerts - mfd.ru
Why Cocrystal Pharma Inc. stock is seen as undervaluedJuly 2025 Reactions & Reliable Volume Spike Trade Alerts - mfd.ru
COCP Should I Buy - Intellectia AI
COCP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Why Cocrystal Pharma Inc. stock is rated strong buyJuly 2025 Macro Moves & Weekly High Potential Stock Alerts - mfd.ru
Is Cocrystal Pharma Inc. benefiting from innovation trendsTrade Analysis Report & Safe Entry Zone Tips - mfd.ru
Why IGTR stock attracts HNW investorsJuly 2025 Outlook & AI Powered Market Trend Analysis - mfd.ru
Market Catalysts: Is Cocrystal Pharma Inc benefiting from innovation trendsIPO Watch & Safe Swing Trade Setup Alerts - baoquankhu1.vn
How cyclical is Cocrystal Pharma Inc.’s revenue streamPortfolio Gains Report & Smart Investment Allocation Insights - mfd.ru
Returns Recap: Can Cocrystal Pharma Inc keep up with sector leadersMarket Sentiment Report & AI Enhanced Execution Alerts - baoquankhu1.vn
What’s the outlook for Cocrystal Pharma Inc.’s sectorTrade Signal Summary & Proven Capital Preservation Methods - mfd.ru
Jobs Data: Can Cocrystal Pharma Inc ride the EV waveMarket Growth Summary & Real-Time Stock Movement Alerts - baoquankhu1.vn
Will Cocrystal Pharma Inc. stock recover after earningsTrade Risk Assessment & Capital Protection Trading Alerts - mfd.ru
Aug Breakouts: Is Cocrystal Pharma Inc stock technically oversold2025 Market Sentiment & Technical Entry and Exit Alerts - baoquankhu1.vn
Stock Recap: What is the earnings history of Cocrystal Pharma IncWeekly Stock Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Growth Review: Is Cocrystal Pharma Inc stock risky to hold nowJuly 2025 Earnings & Safe Investment Capital Preservation Plans - baoquankhu1.vn
COCP SEC FilingsCocrystal Pharma Inc 10-K, 10-Q, 8-K Forms - stocktitan.net
Valuation Update: Can Cocrystal Pharma Inc ride the EV waveQuarterly Trade Review & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Trading Action: What are the risks of holding QDWN2025 Analyst Calls & Verified Trade Idea Suggestions - baoquankhu1.vn
Whale Trades: Is Metropolitan Bank Holding Corp. a top pick in the sectorRate Cut & AI Powered Market Entry Strategies - baoquankhu1.vn
Cocrystal Pharma gains IRB approval for norovirus trial - MSN
Finanzdaten der Cocrystal Pharma Inc-Aktie (COCP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cocrystal Pharma Inc-Aktie (COCP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director |
Feb 06 '26 |
Buy |
0.95 |
50,000 |
47,280 |
1,888,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 31 '25 |
Buy |
0.95 |
50,000 |
47,275 |
1,838,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 30 '25 |
Buy |
0.97 |
20,000 |
19,310 |
1,788,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 26 '25 |
Buy |
0.97 |
40,000 |
38,944 |
1,768,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 24 '25 |
Buy |
0.97 |
25,000 |
24,258 |
1,728,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 26 '25 |
Buy |
0.99 |
4,000 |
3,975 |
1,703,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 25 '25 |
Buy |
0.94 |
20,000 |
18,812 |
1,699,551 |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):